InnoPharmaScreen Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
InnoPharmaScreen Inc. - overview
Established
2009
Location
-, -, South Korea
Primary Industry
Pharmaceuticals
About
Founded in 2009 and based in Incheon, South Korea, InnoPharmaScreen Inc. operates as a developer of a protein chip-based and AI-aided drug discovery platform. As of 2020, it completed two rounds of financing. The company has developed new drug candidates through the new drug development platform and is conducting clinical trials on reserved pipelines such as asthma therapeutics and non-small cell lung cancer therapeutics.
At present, it has 2 clinical and 3 nonclinical pipelines.
Current Investors
AJU IB Investment, Magna Investment, KDB Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.innopharmascreen.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
InnoPharmaScreen Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.